Investors are braced for more Trump tariffs as focus turns to inflation and Fed Chair Jerome Powell's Senate testimony.

Goldman Sachs downgraded Dynavax Technologies Corporation (NASDAQ:DVAX) stock from Neutral to Sell, adjusting the price target downward to $12.00 from the previous $15.00. According to InvestingPro ...

A member of the company's board of directors, Kimbal Musk, sold $27.34 million worth of Tesla stock on February 6.

After an extensive wait, artificial intelligence (AI) appears to have answered the call. Software and systems are being ...

U.S. stock index futures slipped on Tuesday as investors awaited a testimony from Federal Reserve Chair Jerome Powell for ...

Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) has delivered great gains to investors over time -- advancing 600% over the past ...

Discover why DocuSign stock faces challenges with mixed technical signals, weak fundamentals, and overvaluation.

Although most stocks made forward progress in January, a few of them bucked the bigger trend for understandable reasons.

Follow all the latest U.S. market action for Tuesday here as investors get ready for testimony from Fed Chair Jerome Powell, ...

Follow along for live updates on stocks and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

(NASDAQ:MNDY) is a fast-growing productivity platform. Given this introduction, you would have a thought that the stock would ...

Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The decliners were Novo Nordisk (NYSE: NVO), famously the company behind Wegovy, and ...